CGEM Competitors & Alternatives
Compare Cullinan Oncology LLC with similar stocks in the same industry
Biotechnology
CGEM
Main Stock$21.68
Tradestie Score
31
Market Cap
$354.45M
Analyst Upside
+49.3%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RCUS
Arcus Biosciences, Inc.
|
$30.34
|
$1.43B | - | 40 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$17.39
|
$1.42B | - | 39 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$19.65
|
$1.35B | - | 50 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$48.24
|
$1.32B | - | 38 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.70
|
$1.29B | - | 41 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$32.29
|
$1.29B | - | 51 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.89
|
$1.29B | - | 63 | Compare |
|
ZYME
Zymeworks Inc.
|
$28.67
|
$1.28B | - | 30 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$6.93
|
$1.27B | - | 40 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
More CGEM Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2836)
238 stocks in this industry